EUVIMEDEUVIMED entdecken
Crossref

Clinical relevance of genetic variants in the von Willebrand factor according to in‐silico methods

Adriana Inés Woods iD, Débora Marina Primrose iD, Juvenal Paiva iD, Alicia Noemí Blanco iD, María Fabiana Alberto iD, Analía Sánchez-Luceros iD

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Adriana Inés Woods und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Hemostasia y Trombosis, IMEX-CONICET-Academia Nacional de Medicina de Buenos Aires, CABA, Argentina. Hauptthemen laut MEDLINE: von Willebrand Factor, von Willebrand Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical interpretation of genetic variants in the context of the patient's phenotype is a time‐consuming and costly process. In‐silico analysis using in‐silico prediction tools, and molecular modeling have been developed to predict the influence of genetic variants on the quality and/or quantity of the resulting translated protein, and in this way, to alert clinicians of disease likelihood in the absence of previous evidence. Our objectives were to evaluate the success rate of the in‐silico analysis in predicting the disease‐causing variants as pathogenic and the single‐nucleotide variants as neutral, and to establish the reliability of in‐silico analysis for determining pathogenicity or neutrality of von Willebrand factor gene‐associated genetic variants. Using in‐silico analysis, we studied pathogenicity in 31 disease‐causing variants, and neutrality in 61 single‐nucleotide variants from patients previously diagnosed as type 2 von Willebrand disease. Disease‐causing variants and non‐synonymous single‐nucleotide variants were explored by in‐silico tools that analyze the amino acidic sequence. Intronic and synonymous single‐nucleotide variants were analyzed by in‐silico methods that evaluate the nucleotidic sequence. We found a consistent agreement between predictions achieved by in‐silico prediction tools and molecular modeling, both for defining the pathogenicity of disease‐causing variants and the neutrality of single‐nucleotide variants. Based on our results, the in‐silico analysis would help to define the pathogenicity or neutrality in novel genetic variants observed in patients with clinical and laboratory phenotypes suggestive of von Willebrand disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand Factorvon Willebrand DiseasesHumansClinical RelevanceReproducibility of ResultsNucleotides

Stichwörter der Autor:innen

genetic variantsin-silico prediction toolsprotein structure modelingvon Willebrand diseasevon Willebrand factor

Substanzen

von Willebrand FactorNucleotides

Autor:innen und Institutionen

  • Laboratorio de Hemostasia y Trombosis, IMEX-CONICET-Academia Nacional de Medicina de Buenos Aires, CABA, Argentina.
  • Escuela Superior de Ingeniería, Informática y Ciencias Agroalimentarias, Universidad de Morón, Buenos Aires, Argentina.
  • Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires, CABA, Argentina.

ORCID-Profile: Adriana Inés Woods, Débora Marina Primrose, Juvenal Paiva, Alicia Noemí Blanco, María Fabiana Alberto, Analía Sánchez-Luceros

Zitieren

APA

Woods, A. I., Primrose, D. M., Paiva, J., Blanco, A. N., Alberto, M. F., & Sánchez-Luceros, A. (2024). Clinical relevance of genetic variants in the von Willebrand factor according to in‐silico methods. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63430

Vancouver

Woods AI, Primrose DM, Paiva J, Blanco AN, Alberto MF, Sánchez-Luceros A. Clinical relevance of genetic variants in the von Willebrand factor according to in‐silico methods. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63430

BibTeX
@article{Woods2024,
  author = {Woods, Adriana Inés and Primrose, Débora Marina and Paiva, Juvenal and Blanco, Alicia Noemí and Alberto, María Fabiana and Sánchez-Luceros, Analía},
  title = {Clinical relevance of genetic variants in the von Willebrand factor according to in‐silico methods},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63430}
}
Kostenlos starten →